August 27, 2025

High Brain Pain Activity Tied to Better RA Outcomes

"These data highlight the role of subjective patient-related parameters in the response to cytokine inhibition and suggest that a high-volume representation of the disease in the CNS—involving more frontal-associative brain circuits—increases the likelihood to respond to TNF inhibitor.

Conexiant

August 27, 2025

Drug for Dizziness May Increase Falls

Researchers find elevated risk across adult age groups, not just in older adults.

Conexiant

August 25, 2025

Three Years Later, Still Pain-Free?

Cognitive functional therapy demonstrates durable effects on disability and pain intensity at 3 years, with outcomes remaining stable beyond the 12-month mark in patients with chronic low back pain

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 19, 2025

Bedtime Cyclobenzaprine Relieves Fibromyalgia: Randomized Trial

Researchers found bedtime sublingual cyclobenzaprine reduced pain versus placebo and improved sleep, fatigue, and function with mostly mild oral adverse events.

Conexiant

August 18, 2025

Early Risdiplam Use in Presymptomatic SMA Infants

Presymptomatic treatment with risdiplam was associated with improved motor development and survival without permanent ventilation in infants with spinal muscular atrophy (SMA), according to 24-month results from the phase 2 RAINBOWFISH trial published in the New England Journal of Medicine.

Conexiant

August 15, 2025

FDA Approves Non-Opioid Fibromyalgia Therapy

Tonmya reduces fibromyalgia pain versus placebo in phase 3 trials, offering a non-opioid option with a generally well-tolerated safety profile.

Conexiant

August 13, 2025

Low B Vitamins, ApoE e4 May Raise Dementia Risk

Older adults with low B-vitamin status and elevated homocysteine may have increased odds of cognitive dysfunction, and carriers of the ApoE e4 genotype faced compounded risk.

Conexiant

August 12, 2025

Behavioral Therapy Matches Drug for Parkinson’s Bladder 

“This study builds on the emerging literature suggesting behavioral therapy may have utility as an initial therapy for the most common urinary symptoms affecting persons with PD."

Conexiant